Potassium in biology

Synthetaic Partners with Wake Forest University Faculty to Automatically Label Animal Image Data

Retrieved on: 
Wednesday, July 21, 2021

The collaboration between Synthetaic and Wake Forest University will focus on building an AI model to rapidly classify imagery without hand-labeling.

Key Points: 
  • The collaboration between Synthetaic and Wake Forest University will focus on building an AI model to rapidly classify imagery without hand-labeling.
  • The goal is to prove the technologys applications in conservation image data before expanding to other datasets.
  • To learn more about the Anderson Lab at Wake Forest University, visit www.wfu.me/andersonlab .
  • With Synthetaic, you no longer have to wait around to accumulate enough data to start the AI project of your dreams.

CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance the Treatment of Severe Hyperkalemia in Traumatic Injury

Retrieved on: 
Tuesday, May 11, 2021

This follows the successful completion of the previously announced Phase I and Phase II SBIR programs for this application, totaling approximately $1.15 million in previous contract funding.\nCytoSorbents Awarded $1.5M SBIR U.S. Army Contract to Protect Wounded Warfighters From Deadly Complication of Trauma\nDr.

Key Points: 
  • This follows the successful completion of the previously announced Phase I and Phase II SBIR programs for this application, totaling approximately $1.15 million in previous contract funding.\nCytoSorbents Awarded $1.5M SBIR U.S. Army Contract to Protect Wounded Warfighters From Deadly Complication of Trauma\nDr.
  • We look forward to advancing these technologies to clinical usage to help our wounded warfighters and other mass casualty trauma victims.
  • "\nTrauma and crush injury to soft tissue can lead to rapid cell death and the release of a flood of intracellular potassium into the bloodstream.
  • In compromised patients, very high levels of potassium in the blood, or severe hyperkalemia, can lead to dangerously irregular heartbeats called arrhythmias, and sudden cardiac death.

Advisory - CanPrev Natural Health Products Ltd. recalls certain lots of Magnesium Bis-Glycinate Powder 250 because of a packaging error

Retrieved on: 
Saturday, May 8, 2021

To obtain the recommended dose, take 2 teaspoons of the product instead.

Key Points: 
  • To obtain the recommended dose, take 2 teaspoons of the product instead.
  • Use a measuring spoon, not a kitchen spoon.Stop taking the product if you experience diarrhea or abdominal cramps.
  • Using the 20 cc scoop will result in consumers receiving approximately 487 to 498 mg of magnesium instead of the intended daily dose of 250 mg.
  • Magnesium, when taken at doses above 350 mg per day, may cause diarrhea and abdominal cramping.\nThe products were distributed nationally since December 2020.\n'

Ardelyx Announces Upcoming Data Presentation at ISN World Congress of Nephrology 2021

Retrieved on: 
Monday, April 12, 2021

Ardelyx is advancing tenapanor, a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, for which the company's NDA is currently under review by the FDA, with a PDUFA date of April 29, 2021.

Key Points: 
  • Ardelyx is advancing tenapanor, a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, for which the company's NDA is currently under review by the FDA, with a PDUFA date of April 29, 2021.
  • Ardelyx is also advancing RDX013, a potassium secretagogue, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease and has an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.
  • In addition, Ardelyx received FDA approval of IBSRELA (tenapanor) on September 12, 2019.
  • Ardelyx has established agreements with Kyowa Kirin in Japan, Fosun Pharma in China and Knight Therapeutics in Canada for the development and commercialization of tenapanor in their respective territories.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/ardelyx-announces-upcoming-data-...\n"

$132M Japanese Hyperkalemia Industry and Epidemiology Outlook 2020-2030

Retrieved on: 
Monday, March 22, 2021

This report delivers an in-depth understanding of the Hyperkalemia, historical and forecasted epidemiology as well as the Hyperkalemia market trends in Japan.

Key Points: 
  • This report delivers an in-depth understanding of the Hyperkalemia, historical and forecasted epidemiology as well as the Hyperkalemia market trends in Japan.
  • The Hyperkalemia market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted Japan Hyperkalemia market size from 2021 to 2030.
  • The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Prevalent Population of Hyperkalemia, Gender-specific Diagnosed Prevalent of Hyperkalemia, Age-specific Diagnosed Prevalent Cases of Hyperkalemia, Severity-specific Diagnosed Prevalent Cases of Hyperkalemia and Comorbidities-specific Diagnosed Prevalent Cases of Hyperkalemia scenario of Hyperkalemia in Japan from 2018 to 2030.
  • This section provides glimpses of the Hyperkalemia epidemiology in Japan:
    As per this analysis, total number of cases of Hyperkalemia in Japan was 503,103 in 2020.

Hyperkalemia - Japan Market Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 18, 2021

The "Hyperkalemia - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hyperkalemia - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of the Hyperkalemia, historical and forecasted epidemiology as well as the Hyperkalemia market trends in Japan.
  • The Hyperkalemia market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted Japan Hyperkalemia market size from 2021 to 2030.
  • This section includes a glimpse of the Hyperkalemia Japan market:
    The market size of Hyperkalemia in Japan market was USD 132.77 million in 2020.

Global Potassium Iodide Industry (2020 to 2027) - Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 3, 2020

The "Potassium Iodide - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Potassium Iodide - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The 193-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021.
  • The U.S. Market is Estimated at $208.8 Million, While China is Forecast to Grow at 9.5% CAGR
    The Potassium Iodide market in the U.S. is estimated at US$208.8 Million in the year 2020.
  • In the global Nutrition segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment.

Itronics' Rock Kleen Technology Seen As Way U.S. Government Can Produce Key, Critical Minerals in the U.S.

Retrieved on: 
Tuesday, October 13, 2020

Both Manganese and agricultural potassium are Critical Minerals.

Key Points: 
  • Both Manganese and agricultural potassium are Critical Minerals.
  • "Our Rock Kleen Technology is exactly what our Government needs to recover minerals critical to make airplanes, computers, cell phones, generate electricity and to produce electronic products," said Itronics President Dr. John Whitney.
  • The Executive Order states: "These minerals are indispensable to our country and we presently lack the capacity to produce them in processed form in the quantities needed.
  • The U.S. has no domestic production for 14 critical minerals and is completely dependent on imports.

Licorice Root Market - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 30, 2020

The "Licorice Root Market - By Product Form, By End-Use Industry, and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Licorice Root Market - By Product Form, By End-Use Industry, and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global Licorice Root market, is set to record the CAGR of nearly 5.3% over the period from 2020 to 2026
    The report offers assessment and analysis of the Licorice Root market on a global and regional level.
  • The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).
  • Licorice root comprises of a tribasic glycyrrhizin that is in the form of calcium salts & potassium salts blend.

Nutraveris Launches Online Platform for U.S. Dietary Supplement Compliance

Retrieved on: 
Thursday, September 10, 2020

DEERFIELD, Ill. and PLOUFRAGAN, France, Sept. 10, 2020 /PRNewswire/ -- Nutraveris , a FoodChain ID company, launches Nutraveris Online [NOL], an integrated platform that uses artificial intelligence to evaluate and monitor U.S. dietary supplement data and compliance.

Key Points: 
  • DEERFIELD, Ill. and PLOUFRAGAN, France, Sept. 10, 2020 /PRNewswire/ -- Nutraveris , a FoodChain ID company, launches Nutraveris Online [NOL], an integrated platform that uses artificial intelligence to evaluate and monitor U.S. dietary supplement data and compliance.
  • Nutraveris is the leading EU scientific and regulatory affairs consultancy and technology software provider covering the health, nutrition, and supplement markets.
  • A second feature, NOL Compliance, provides insights for new product launches and includes automated compliance analysis, label generation, and on-going monitoring and alerts.
  • NOL (Nutraveris Online) is the most effective on-line platform to help you create, label, and launch dietary supplements, providing real-time regulatory, scientific, and market data solutions.